Latest filing published 10 Aug 2026 for Phibro Animal Health CORP. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Daniel M. Bendheim appears in our data through filings on Phibro Animal Health Corp shares, published by SEC (Form 4). Between 15 August 2025 and 6 August 2026, the trades on record add up to 3 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The record was last updated on 10 August 2026 with a share grant in Phibro Animal Health Corp. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations